Braidwell’s QuidelOrtho QDEL Stock Holding History

Braidwell’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-300,437	Closed	-$25.7M	–	94
2022 Q4	$25.7M	Buy	+300,437	New	+$25.4M	0.86%	45

Other funds holding QDEL

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Braidwell's QDEL Position: Q1 2023 in Review

Braidwell sold out of QuidelOrtho (QDEL) in Q1 2023, closing a stake of 300,437 shares — an estimated $25.7M sold.

Braidwell first reported a position in QDEL in Q4 2022 and held it in 1 quarter. The position peaked at $25.7M in Q4 2022. 331 funds tracked by Wall St. Rank hold QDEL as of Q1 2023.

Braidwell reported no remaining QuidelOrtho position as of Q1 2023 after selling out during the quarter.
Braidwell sold 300,437 QuidelOrtho shares in Q1 2023, an estimated $25.7M.
Braidwell first reported a position in QuidelOrtho in Q4 2022 and held it in 1 quarter.
Braidwell's QuidelOrtho position peaked at $25.7M in Q4 2022.
331 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2023.

Based on Braidwell's 13F filing for Q1 2023, filed 15 May 2023.